BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin CL, Kao JH. Optimal management of hepatocellular carcinoma: challenges and opportunities. J Gastroenterol Hepatol 2010;25:1336-8. [PMID: 20659219 DOI: 10.1111/j.1440-1746.2010.06373.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Lin C, Kao J. Review article: the prevention of hepatitis B-related hepatocellular carcinoma. Aliment Pharmacol Ther 2018;48:5-14. [DOI: 10.1111/apt.14683] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
2 Xu X, Yuan G, Deng J, Guo H, Xiang M, Yang F, Ge W, Chen S. Inhibition of 12-lipoxygenase reduces proliferation and induces apoptosis of hepatocellular carcinoma cells in vitro and in vivo. Hepatobiliary & Pancreatic Diseases International 2012;11:193-202. [DOI: 10.1016/s1499-3872(12)60147-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
3 Liu L, Shah SS, Naini BV, French S, Wu T, Torbenson MS, Chandan VS. Immunostains Used to Subtype Hepatic Adenomas Do Not Distinguish Hepatic Adenomas From Hepatocellular Carcinomas. American Journal of Surgical Pathology 2016;40:1062-9. [DOI: 10.1097/pas.0000000000000624] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
4 Wu L, Zhang Y, Zhu Y, Cong Q, Xiang Y, Fu L. The effect of LOXL2 in hepatocellular carcinoma. Mol Med Rep 2016;14:1923-32. [PMID: 27430160 DOI: 10.3892/mmr.2016.5474] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
5 Evason KJ, Grenert JP, Ferrell LD, Kakar S. Atypical hepatocellular adenoma-like neoplasms with β-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas. Hum Pathol. 2013;44:750-758. [PMID: 23084586 DOI: 10.1016/j.humpath.2012.07.019] [Cited by in Crossref: 58] [Cited by in F6Publishing: 41] [Article Influence: 5.8] [Reference Citation Analysis]
6 Kao JH, Chen PJ, Chen DS. Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects. Adv Cancer Res. 2010;108:21-72. [PMID: 21034965 DOI: 10.1016/b978-0-12-380888-2.00002-9] [Cited by in Crossref: 61] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
7 Bridges JF, Gallego G, Blauvelt BM. Controlling liver cancer internationally: A qualitative study of clinicians' perceptions of current public policy needs. Health Res Policy Syst 2011;9:32. [PMID: 21798002 DOI: 10.1186/1478-4505-9-32] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
8 Lin C, Tseng T, Kao J. What can we learn from hepatitis B virus clinical cohorts? Liver Int 2015;35:91-9. [DOI: 10.1111/liv.12716] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]